Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Institute Installs Sequenom’s MassArray And Genomica Software



AITHERSBURG, Md.--Sequenom has installed its MassArray system at the US National Cancer Institute’s Advanced Technology Center here for use in analysis of single-nucleotide polymorphisms that occur in genes involved with cancer and other diseases. The system combines Sequenom’s proprietary enzymology and bioinformatics in a miniaturized chip-based format with mass spectrometry technology. The deal marks the third installation by the German company of its MassArray system in the US, and the fifth worldwide.

The cancer institute also recently licensed pharmaco-genomics tools from Genomica. Genomica’s CEO Theresa Ayers said her company’s Discovery Manager tool will enable the institute to integrate the data in its bioinformatics pipeline, from pedigree information to the linkage analysis and sequence analysis stages of disease studies.

Filed under

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.